STOCK TITAN

PDS Biotechnology Corporation (PDSB) Net Income by Year

PDSB

PDS Biotechnology Corporation reported a net loss of $34.5M in fiscal year 2025. This represents an increase of 8.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $33.7M net loss. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters PDS Biotechnology Corporation has filed alongside them.

FY2025 annual
Net Income -$34.5M
YoY +8.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PDSB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-K
Net Income-$33.7M-$34.5M+8.3%-$37.6M+12.4%-$42.9M-5.1%-$40.9M-141.5%-$16.9M-13.9%-$14.8M-112.1%-$7.0MN/A-$50.9M-31.0%-$38.8M-38.3%-$28.1M-130.1%-$12.2M-77.3%-$6.9M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

PDSB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-KQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-KQ2'2410-KQ1'2410-KQ4'2310-QQ3'2310-Q
Net Income-$9.8M-3.4%-$7.3M+13.4%-$7.6M+4.9%-$9.0M+16.0%-$9.4M-13.3%-$8.5M+19.9%-$8.0M+27.0%-$10.7M+1.1%-$8.3M+27.8%-$10.6M-9.8%-$10.9M+43.1%-$10.8M-46.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More PDS Biotechnology Corporation financials

Frequently Asked Questions

What was PDS Biotechnology Corporation's net income in fiscal year 2025?

PDS Biotechnology Corporation reported a net loss of $34.5M in fiscal year 2025.

How fast is PDS Biotechnology Corporation's net income growing?

PDS Biotechnology Corporation (PDSB) net income rose by 8.3% year over year, from -$37.6M to -$34.5M in fiscal year 2025.

What is PDS Biotechnology Corporation's net income over the last twelve months?

PDS Biotechnology Corporation (PDSB) reported a $33.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, PDS Biotechnology Corporation (PDSB) net income went from -$6.9M in fiscal year 2013 to -$34.5M in fiscal year 2025.

PDS Biotechnology Corporation (PDSB) reported -$9.8M in net income in Q2 2026. This represents a decrease of 3.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what PDS Biotechnology Corporation (PDSB) reported on that line in every period on record.